» Articles » PMID: 33992825

Diabetic Wound Healing in Soft and Hard Oral Tissues

Overview
Journal Transl Res
Publisher Elsevier
Specialty Pathology
Date 2021 May 16
PMID 33992825
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

There is significant interest in understanding the cellular mechanisms responsible for expedited healing response in various oral tissues and how they are impacted by systemic diseases. Depending upon the types of oral tissue, wound healing may occur by predominantly re-eptihelialization, by re-epithelialization with substantial new connective tissue formation, or by a a combination of both plus new bone formation. As a result, the cells involved differ and are impacted by systemic diaseses in various ways. Diabetes mellitus is a prevalent metabolic disorder that impairs barrier function and healing responses throughout the human body. In the oral cavity, diabetes is a known risk factor for exacerbated periodontal disease and delayed wound healing, which includes both soft and hard tissue components. Here, we review the mechanisms of diabetic oral wound healing, particularly on impaired keratinocyte proliferation and migration, altered level of inflammation, and reduced formation of new connective tissue and bone. In particular, diabetes inhibits the expression of mitogenic growth factors whereas that of pro-inflammatory cytokines is elevated through epigenetic mechanisms. Moreover, hyperglycemia and oxidative stress induced by diabetes prevents the expansion of mesengenic cells that are involved in both soft and hard tissue oral wounds. A better understanding of how diabetes influences the healing processes is crucial for the prevention and treatment of diabetes-associated oral complications.

Citing Articles

The Impact of a Lacto-Ovo Vegetarian Diet on Post-Operative Recovery and Wound Healing Following Mandibular Third Molar Extraction-A Prospective Study.

Baranowska A, Pitulaj A, Makar M, Kowalewski K, Dominiak S, Kubasiewicz-Ross P Nutrients. 2025; 17(5).

PMID: 40077629 PMC: 11902192. DOI: 10.3390/nu17050759.


A retrospective, cross-sectional analysis of the dental status and needs of patients taking vascular endothelial growth factor (VEGF) antagonists.

Raucci A, France K Clin Oral Investig. 2025; 29(3):151.

PMID: 39984788 PMC: 11845543. DOI: 10.1007/s00784-025-06230-7.


Editorial: Impact of uncontrolled diabetes on oral disease progression and healing.

Moseley R, Waddington R Front Dent Med. 2025; 5:1487051.

PMID: 39917695 PMC: 11797842. DOI: 10.3389/fdmed.2024.1487051.


Role of oxidative stress in impaired type II diabetic bone repair: scope for antioxidant therapy intervention?.

Li P, Alenazi K, Dally J, Woods E, Waddington R, Moseley R Front Dent Med. 2025; 5:1464009.

PMID: 39917650 PMC: 11797775. DOI: 10.3389/fdmed.2024.1464009.


Effect of ozone oil and non-surgical periodontal treatment in patients with type 2 diabetes. In-vivo and in-vitro studies with fibroblasts and Candida albicans.

Carmo R, Corner A, Martins E, Ouverney G, Thurler Junior J, Robbs B J Appl Oral Sci. 2025; 33:e20240080.

PMID: 39841769 PMC: 11805463. DOI: 10.1590/1678-7757-2024-0080.


References
1.
Shaikh-Kader A, Houreld N, Rajendran N, Abrahamse H . The link between advanced glycation end products and apoptosis in delayed wound healing. Cell Biochem Funct. 2019; 37(6):432-442. DOI: 10.1002/cbf.3424. View

2.
Stegenga M, van der Crabben S, Blumer R, Levi M, Meijers J, Serlie M . Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood. 2008; 112(1):82-9. PMC: 2435690. DOI: 10.1182/blood-2007-11-121723. View

3.
Wyganowska-Swiatkowska M, Urbaniak P, Nohawica M, Kotwicka M, Jankun J . Enamel matrix proteins exhibit growth factor activity: A review of evidence at the cellular and molecular levels. Exp Ther Med. 2015; 9(6):2025-2033. PMC: 4489198. DOI: 10.3892/etm.2015.2414. View

4.
Walmsley G, Rinkevich Y, Hu M, Montoro D, Lo D, McArdle A . Live fibroblast harvest reveals surface marker shift in vitro. Tissue Eng Part C Methods. 2014; 21(3):314-21. PMC: 4346232. DOI: 10.1089/ten.TEC.2014.0118. View

5.
Cabras T, Pisano E, Mastinu A, Denotti G, Pusceddu P, Inzitari R . Alterations of the salivary secretory peptidome profile in children affected by type 1 diabetes. Mol Cell Proteomics. 2010; 9(10):2099-108. PMC: 2953908. DOI: 10.1074/mcp.M110.001057. View